SalT Reduction InterVEntion: Metabolic, Behavioral and Health Consequences of Reducing Salt in Bread
STRIVE
SalT Reduction InterVEntion: Examination of the Metabolic, Behavioral and Health Consequences of Reducing Salt Intake. A Randomized Controlled Trial in a Real Life Setting
1 other identifier
interventional
316
1 country
1
Brief Summary
The trial is conducted as a randomized controlled trial including children and adults recruited as families. The families are randomly allocated into three groups to investigate the effect of different salt reduction strategies in a period of 3-4 months. Families in the first intervention group are receiving salt reduced bread. Families in the second intervention group are receiving salt reduced bread in combination with dietary counselling to reduce salt and increase potassium intake. Families in the control group are receiving bread with a regular content of salt and no dietary counselling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 30, 2018
CompletedFirst Posted
Study publicly available on registry
January 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2019
CompletedJuly 12, 2019
July 1, 2019
1.2 years
November 30, 2018
July 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline sodium level in 24 hour urine at 4 months
Adults average of 3 repeated 24 hour urine, children a single 24hour urine collection; excluding urine first morning including urine of the following morning. Completeness evaluated in adults by Para-Amino-Benzoic-Acid (PABA).
Measurements at Baseline and at 4 month.
Secondary Outcomes (6)
Change from Baseline potassium level in 24 hour urine at 4 months
Measurements at Baseline and at 4 month.
Change from Baseline Systolic blood pressure at 4 months
Measurements at Baseline and at 4 month.
Change from Baseline Diastolic blood pressure at 4 months
Measurements at Baseline and at 4 month.
Change from Baseline Adrenaline and Noradrenaline levels in plasma at 4 months
Measurements at Baseline and at 4 month.
Change from Baseline Renin and Aldosterone levels in plasma at 4 months
Measurements at Baseline and at 4 month.
- +1 more secondary outcomes
Other Outcomes (10)
Change from Baseline Glucose levels in plasma at 4 months
Measurements at Baseline and at 4 month.
Change from Baseline HbA1C levels in full blood at 4 months
Measurements at Baseline and at 4 month.
Change from Baseline Cholesterol levels in plasma (LDL, HDL, total cholesterol and triglycerides) at 4 months
Measurements at Baseline and at 4 month.
- +7 more other outcomes
Study Arms (3)
Salt reduced bread
EXPERIMENTALBread with reduced salt content
Dietary advice and Salt reduced bread
EXPERIMENTALbread with reduced salt content, dietary advice
Normal bread
PLACEBO COMPARATORBread with standard salt content
Interventions
Bread with gradually lowered salt content
Participants will receive information on how to lower salt and increase potassium intake
Eligibility Criteria
You may qualify if:
- Participants living with children
- Adults 18-69 years
- Children 3-17 years
- Daily intake of bread
You may not qualify if:
- Diabetes
- Cardiovascular disease
- Antihypertensive treatment
- Lipid-lowering treatment
- Pregnancy
- U-albumin \> 300 mg/day
- Celiac disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center fot Clinical Research and Prevention
Glostrup Municipality, Capital Region, 2600, Denmark
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ulla Toft, MSc, PhD
Capital Region, Copenhagen, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The participants will be unaware of the treatment groups and the salt content of the bread products will be blinded to the participants. Nurses examining participants at baseline and follow-up will be unaware of which intervention group the families were randomized into. The primary outcome measures will be blinded to the outcome assessors.
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, PhD, MSc, Head of Section of Health Promotion and Prevention
Study Record Dates
First Submitted
November 30, 2018
First Posted
January 22, 2019
Study Start
February 1, 2018
Primary Completion
April 30, 2019
Study Completion
April 30, 2019
Last Updated
July 12, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share